1
Matsumoto Takahiro, Kamo Izumi, Nomura Izumi: Tricyclic heterocyclic compound and use thereof. Takeda Pharmaceutical Company, Matsumoto Takahiro, Kamo Izumi, Nomura Izumi, TAKASHIMA Hajime, January 17, 2008: WO/2008/007661 (14 worldwide citation)

Disclosed is a tricyclic heterocyclic compound having a serotonin 5-HT2C receptor activating effect and the like. Specifically disclosed is a serotonin 5-HT2C receptor activator containing a compound represented by the formula (I) below, a salt thereof or a prodrug thereof. (I) (In the formula, the ...


2
Maekawa Tsuyoshi, Ujikawa Osamu, Abe Hidenori, Nomura Izumi: Arylalkanoic acid derivative. Takeda Pharmaceutical, September 5, 2007: EP1829863-A1 (9 worldwide citation)

A compound represented by the formula (I): wherein Ar is an optionally substituted aromatic ring; Xa, Xc, Ya, Yc, Z 1 and Z 2 are each a bond, O, S, -CO-, -CS-, - CR 3 (OR 4 ) -, -NR 5 -, -SO-, -SO 2 -, -CONR 6 - or -NR 6 CO- (wherein R 3 , R 4 , R 5 and R 6 are as defined in the specification); Xb ...


3
Roppongi Tetsuya, Mogi Yuko, Nomura Izumi: Magnetic head for perpendicular magnetic recording. TDK, September 28, 2001: JP2001-266310 (5 worldwide citation)

PROBLEM TO BE SOLVED: To provide a magnetic head for perpendicular magnetic recording easily manufactured with simple structure and capable of easily achieving a high recording density.SOLUTION: This magnetic head for perpendicular magnetic recording is constructed in such a manner that the magnetic ...


4
Nomura Izumi, Morita Haruyuki, Shiraishi Kazumasa, Kawai Mitsuyoshi, Wada Takeshi: Magnetic head device and magnetic disk device equipped with the head device. TDK, July 28, 2000: JP2000-207720 (3 worldwide citation)

PROBLEM TO BE SOLVED: To provide a magnetic head device for positioning an IC chip for a head at a position relatively close to a magnetic head, and for reducing the effect due to heat to an allowable limited value. SOLUTION: This magnetic head device is constituted of a head slider 3 equipped with ...


5
Nomura Izumi, Roppongi Tetsuya: Thin-film magnetic head and its manufacture. TDK, September 14, 2000: JP2000-251219 (2 worldwide citation)

PROBLEM TO BE SOLVED: To secure sufficient writing capability and to facilitate the manufacture by preventing magnetic saturation before magnetic flux reaches the tip of a magnetic pole part, even when the magnetic pole width is made small. SOLUTION: The upper magnetic layer of an induction type mag ...


6

7
Nomura Izumi, Morita Haruyuki, Shiraishi Ichimasa: Magnetic head device. TDK, wang sibeng, June 21, 2000: CN99126328

There is disclosed a magnetic head device in which a head IC chip may be located relatively closer to a magnetic head and a thermal effect may be controlled to be within a range of acceptable degree. Said magnetic head device comprises a head slider having a magnetic head, a suspension member which ...


8

9
MATSUMOTO TAKAHIRO, NOMURA IZUMI: THIENOOXAZEPINE DERIVATIVE, THIENOXAZEPINDERIVAT, DÉRIVÉ DE THIÉNOOXAZÉPINE. TAKEDA PHARMACEUTICAL, June 13, 2012: EP2463290-A1

Provision of a compound having a serotonin 5-HT 2C receptor activating action. A compound represented by the formula (I): wherein each symbol is as described in the description, or a salt thereof.


10
TOKUMARU Kazuyuki, NOMURA Izumi, ITO Yoshiteru, ASO Kazuyoshi: チアゾール誘導体, Dérivé de thiazole, Thiazole derivative. Takeda Pharmaceutical Company, TOKUMARU Kazuyuki, NOMURA Izumi, ITO Yoshiteru, ASO Kazuyoshi, TAKASHIMA Hajime, November 24, 2011: WO/2011/145735

Disclosed is a compound which has agonist activity against GPR52 and is useful as a prophylactic or therapeutic agent for mental diseases such as schizophrenia, and the like.Specifically disclosed is a compound represented by formula (I) (wherein the symbols are as defined in the description) or a s ...